Back to Search
DR. HADI YAZIJI M.D.
M.D.
Anatomic Pathology & Clinical Pathology Physician
NPI: 1356313548IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cytopathology Physician
Pathology — Cytopathology
Code: 207ZC0500X
ME88998(FL)
Clinical Pathology/Laboratory Medicine Physician
Pathology — Clinical Pathology/Laboratory Medicine
Code: 207ZP0105X
ME88998(FL)
Anatomic Pathology & Clinical Pathology PhysicianPrimary
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
ME88998(FL)
Education
OTHER
Class of 1989
Research & Publications (20)
Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry.
PMID 18931614·Appl Immunohistochem Mol Morphol·2008
6-review
Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity.
PMID 16554731·Mod Pathol·2006
8-other
Recommendations for improved standardization of immunohistochemistry.
PMID 17525622·Appl Immunohistochem Mol Morphol·2007
6-review
Begin at the beginning, with the tissue! The key message underlying the ASCO/CAP Task-force Guideline Recommendations for HER2 testing.
PMID 17721265·Appl Immunohistochem Mol Morphol·2007
8-other
Aggressive behavior of stage I ovarian mucinous tumors lacking extensive infiltrative invasion: a report of four cases and review of the literature.
PMID 15968194·Int J Gynecol Pathol·2005
5-case
Testing for epidermal growth factor receptor in lung cancer: have we learned anything from HER-2 testing?
PMID 15337816·J Clin Oncol·2004
8-other
Wilms tumor gene product: sensitive and contextually specific marker of serous carcinomas of ovarian surface epithelial origin.
PMID 15354736·Appl Immunohistochem Mol Morphol·2004
8-other
Accuracy and precision in HER2/neu testing in breast cancer: are we there yet?
PMID 14991529·Hum Pathol·2004
8-other
Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.
PMID 12502930·Am J Surg Pathol·2003
4-observational
CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas.
PMID 12604886·Am J Surg Pathol·2003
4-observational
P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies.
PMID 12459625·Am J Surg Pathol·2002
8-other
Controversies and guidelines in tissue-based HER-2/neu testing in breast cancer.
PMID 12090214·MLO Med Lab Obs·2002
4-observational
Testing for HER-2/neu in breast cancer: is fluorescence in situ hybridization superior in predicting outcome?
PMID 12409642·Adv Anat Pathol·2002
4-observational
E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions.
PMID 11293901·Am J Clin Pathol·2001
8-other
Renal angiomyolipoma: further immunophenotypic characterization of an expanding morphologic spectrum.
PMID 11371226·Arch Pathol Lab Med·2001
8-other
Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis.
PMID 11392876·Am J Clin Pathol·2001
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8700 W FLAGLER ST STE 100
MIAMI, FL 33174 - Phone
- (305) 267-7979
Quick Facts
- NPI
- 1356313548
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile